InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Lee Tien-Li. Officer active across 1 company, notably Aardvark Therapeutics, Inc.. Cumulatively, 7 reports have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €230k. Activity tracked since 28 August 2025. The latest transaction was disclosed on 11 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Lee Tien-Li is Chief Executive Officer at Aardvark Therapeutics, Inc. on XNAS. The person has 7 filings in total, and among the sampled recent filings, buys amount to EUR 229638 and sells to EUR 0, between 2025-02-19 and 2025-12-12, with the modal transaction nature indicated as Acquisition.